Episode 10 (February 23, 2024): Researchers from Francis Collins’ lab developed an efficient CRISPR prime editing protocol to generate isogenic-induced pluripotent stem cell (iPSC) lines carrying heterozygous or homozygous alleles for putatively causal single nucleotide variants. An RNA-based system known as PRINT can create and introduce site-specific, safe, and stable transgenes into the human genome. Astellas Pharma and Kelonia announced a nearly $800 million research collaboration and license agreement to develop innovative universal, off-the-shelf in vivo CAR T cell therapies. Fourth-quarter earnings and revenue fell short of expectations as Biogen worked to eliminate 1,000 jobs (11.5% of its workforce), among other cost-cutting actions, and restructured its pipeline after a slow start.
Plus, an interview with Andrea Choe, founder and chief executive officer at Holoclara.
Listed below are key references to the GEN stories, media, and other items discussed in this episode of Touching Base:
Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing
The CRISPR Journal, February 14, 2024
Addressing Scientific Misconduct: An Interview with Elisabeth Bik
By Uduak Thomas, GEN Biotechnology, February 15, 2024
StockWatch: Biogen’s Q4 Results Disappoint Analysts
By Alex Philippidis, GEN Edge, February 18, 2024
Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies
By Jonathan D. Grinstein, PhD, GEN Edge, February 20, 2024
PRINT: Precise RNA-Mediated Insertion of Transgenes
GEN, February 21, 2024
Hosted on Acast. See acast.com/privacy for more information.
DNA Day: Deep Dive
How Biotechs Are Plugging AI into Drug Discovery Problems
Launch of Nvelop Therapeutics for Delivery of Genetic Cargo, AACR Recap
Dried Blood COVID Dx, Cryo-Shocked Tumor Cell Delivery Vehicles, Verve Halts Trial, Iambic Starts Trial, and Diagonal Therapeutics Launches
AI in Drug Discovery and Precision Medicine: Nvidia GTC and Precision Med TRI-CON
Optimizing Nanoparticles and Messenger RNAs with Multiple “Tails”
NanoString Finds a Buyer, Slide Tags Enter in Early Access as Curio Trekker, Cellares Unveils Cell Therapy Manufacturing Platform
International Women’s Day, Nanoparticles and Delivery, Novo Nordisk’s Expansion, and Organoids for Congenital Conditions
Moderna Gets Back to Its Roots, Form Bio and Ginkgo Bioworks Team Up, and Under-the-Radar Rare Autoimmune Diseases
CRISPRed Pigs, Exscientia Fires CEO, & AGBT Roundup; Christian Henry
Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
Genome Interpretation, Nanoparticles, Gene Therapy, 2024 IPOs; Nautilus Biotechnology
Restoring Hearing Loss, CAR T Manufacturing, DNA-Based Medicines, Nvidia and Recursion; Eric Topol
Alzheimer’s Disease, Monkey Cloning, Cytokinetics Stock; Jen Nwankwo
J.P. Morgan 2024: Illumina, 10x, Danaher, AI; Liberate Bio
Novartis and Voyager, JPM Ahead, Epigenetic Engineering; Alex Aravanis
Launch of Tome Biosciences, AI scientist, mRNA vaccines
Autism, AI and Epigenetics; Nevan Krogan
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Unexplainable
Stuff To Blow Your Mind
The Science of Life with Dr. Raven Baxter